GIM
CAH icon

Greylin Investment Management’s Cardinal Health CAH Stock Holding History

Greylin Investment Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.76M Sell
17,882
-5,840
-25% -$595K 0.29% 38
2024
Q1 		$2.65M Sell
23,722
-4,360
-16% -$470K 0.43% 35
2023
Q4 		$2.83M Sell
28,082
-11,190
-28% -$1.11M 0.49% 35
2023
Q3 		$3.41M Sell
39,272
-5,650
-13% -$511K 0.61% 31
2023
Q2 		$4.25M Sell
44,922
-31,864
-41% -$2.69M 0.77% 27
2023
Q1 		$5.8M Sell
76,786
-39,082
-34% -$2.95M 1.06% 22
2022
Q4 		$8.91M Sell
115,868
-34,723
-23% -$2.64M 1.64% 14
2022
Q3 		$10M Sell
150,591
-52,449
-26% -$3.32M 2.09% 11
2022
Q2 		$10.6M Sell
203,040
-3,877
-2% -$220K 2.05% 13
2022
Q1 		$11.7M Buy
206,917
+1,137
+0.6% +$60.9K 2.02% 10
2021
Q4 		$10.6M Buy
205,780
+100,412
+95% +$4.92M 2% 9
2021
Q3 		$5.21M Buy
105,368
+72,253
+218% +$3.92M 1.07% 19
2021
Q2 		$1.89M Buy
33,115
+1,395
+4% +$81.5K 0.37% 38
2021
Q1 		$1.93M Buy
+31,720
New +$1.75M 0.4% 36

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Greylin Investment Management's CAH Position: Q2 2024 in Review

Greylin Investment Management reduced its Cardinal Health (CAH) stake by 25% in Q2 2024, selling an estimated $595K and leaving 17,882 shares worth $1.76M. The position accounts for 0.29% of the portfolio, ranked #38.

Greylin Investment Management first reported a position in CAH in Q1 2021 and has held it in 14 quarters since. The position peaked at $11.7M in Q1 2022. 1,010 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Greylin Investment Management held 17,882 shares of Cardinal Health worth $1.76M as of Q2 2024.
  • Greylin Investment Management sold 5,840 Cardinal Health shares in Q2 2024, an estimated $595K.
  • Cardinal Health made up 0.29% of Greylin Investment Management's portfolio in Q2 2024, its #38 holding.
  • Greylin Investment Management first reported a position in Cardinal Health in Q1 2021 and has held it in 14 quarters since.
  • Greylin Investment Management's Cardinal Health position peaked at $11.7M in Q1 2022.
  • 1,010 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.